瀏覽其他金融產品
Avidity Biosciences, Inc.
RNAM重點摘要
最後更新: 2026-04-13- •Replimune (REPLI) closed at $4.76 on April 10, 2026 — a ~20% single-day drop and 51% YTD decline following a second FDA Complete Response Letter for RP1.
- •Leverage risk is extreme: a 50x long CFD opened at $5.91 would have been liquidated intraday, as the 20% decline represents ~10x the initial margin at that leverage level.
- •A February 2026 SEC filing warned a second rejection could make RP1 development 'no longer viable,' with Phase 3 completion not expected until January 2029.
- •Cross-market contagion targets biotech ETFs (XBI, IBB) as the FDA rejection reinforces sector-wide regulatory uncertainty flagged by nearly half of RBC Capital Markets-surveyed investors.
- •FDA leadership transition (Vinay Prasad departing by end of April 2026) adds short-term regulatory uncertainty across clinical-stage oncology names.
價格及市場結構
市況形態狀態
最新動態
Replimune 年初至今暴跌 56% 於第二次 FDA 拒絕後：槓桿風險與生技產業傳染
據 FierceBiotech 和 BioPharma Dive 報導，美國食品藥品監督管理局 (FDA) 在 2026 年 4 月 10 日發出了第二封完整回應信 (CRL)，拒絕 Replimune Group (NASDAQ: REPLI) 的 RP1 (vusolimogene oderparepvec) 用於不可切除進展期皮膚黑色素瘤。FDA 的治療產品辦公室一致認定 Phase 1/2
Replimune第二次FDA拒絕：裁員為生物科技CFD交易者信號帶來二元風險崩潰
在2026年4月10日，美國食品藥品管理局（FDA）發佈了第二封完整回應函（CRL），拒絕Replimune Group, Inc.（NASDAQ: REPL）重新提交的RP1（vusolimogene oderparepvec）生物製劑許可申請，這是一種針對晚期黑色素瘤的腫瘤溶解免疫療法，與百時美施貴寶的Opdivo聯合使用。據FierceBiotech和STAT News報導，此次拒絕緊隨20
Replimune的RP1面臨第二次FDA裁決：4月10日對生技CFD交易者的意義
Replimune Group Inc.（NASDAQ: REPL）於2025年7月22日收到了FDA的完整回應信（CRL），拒絕了其針對RP1的生物製劑許可申請——這是一種溶瘤單純疱疹病毒，與百時美施貴寶的nivolumab（Opdivo）聯合用於抗PD-1耐藥的晚期黑色素瘤。根據FierceBiotech和STAT News的報導，FDA認為單臂IGNYTE試驗（n=140）證據不足，指出缺乏
Get Started with Avidity Biosciences, Inc.
Start trading Avidity Biosciences, Inc. on CoinUnited.io with industry-leading leverage and zero fees.
Trade with Leverage
Trade RNAM CFDs with up to 1000x leverage on CoinUnited.io.
- Up to 1000x leverage
- Zero trading fees
- Advanced risk management tools
Explore Stocks
Browse the full stocks market on CoinUnited.io with 125+ instruments.
- 125+ stocks instruments
- Real-time market data
- Professional charting tools
Learn Stocks Trading
Read our in-depth research and analysis on stocks markets.
- Expert market analysis
- Technical analysis basics
- Daily market insights
How to Trade Avidity Biosciences, Inc.: Step-by-Step Guide
Learn how to trade Avidity Biosciences, Inc. (RNAM) on CoinUnited.io with up to 1000x leverage and zero trading fees. Follow this simple step-by-step guide to start CFD trading today.
Create Your CoinUnited.io Account
Sign up at CoinUnited.io in under a minute. You'll need an email address to get started.
- ✓Quick and free registration
- ✓Email and password setup
- ✓Two-factor authentication for security
Verify Your Identity
Complete the KYC verification process to unlock full trading features and higher limits.
- ✓Upload government-issued ID
- ✓Proof of address document
- ✓Usually verified within minutes
Deposit Funds
Fund your account using one of the supported deposit methods.
Deposit Methods
- •Cryptocurrency deposits (BTC, ETH, USDT)
- •Bank transfer available
- •No minimum deposit requirement
Find RNAM in the Stocks Section
Navigate to the stocks market section and search for RNAM. You can trade Avidity Biosciences, Inc. as a CFD with up to 1000x leverage.
- ✓Search for "RNAM" in the trading platform
- ✓Select CFD trading mode
- ✓Review the current price and market data
Place Your Trade
Choose your position direction (long or short), set your leverage, and enter your position size to trade Avidity Biosciences, Inc..
- ✓Long (buy) if you expect RNAM to rise
- ✓Short (sell) if you expect RNAM to fall
- ✓Set stop-loss and take-profit levels
Monitor & Manage Risk
Keep track of your open positions and manage risk with stop-loss orders and position sizing.
- ✓Monitor P&L in real-time
- ✓Adjust stop-loss as needed
- ✓Never risk more than you can afford to lose
Order Types
Market Order
Execute immediately at the current market price. Best for quick entries.
Limit Order
Set a specific price to enter. The order fills only when the market reaches your price.
Stop-Loss Order
Automatically close your position at a specified price to limit potential losses.
Important Tips
- • Start with a small position to understand how leverage works
- • Always set a stop-loss to protect your capital
- • Higher leverage amplifies both gains and losses
- • Never invest more than you can afford to lose
標籤
Similar Stocks Assets
Explore other stocks instruments in the same sector as Avidity Biosciences, Inc.. Compare performance and find trading opportunities.
Snap Inc.
Applied Optoelectronics, Inc.
D-Wave Quantum Inc.
Roblox Corporation
Redwire Corporation
免責聲明與參考資料
重要風險提示
本平台所載全部 Avidity Biosciences, Inc. 價格預測與展望僅供資訊及教育用途，並不構成任何形式的財務建議、投資推薦或指引。
加密貨幣市場波動極高且難以預測，過去表現不代表未來結果。上述預測基於數學模型、歷史數據分析及各類技術指標，無法涵蓋不可預見的市場事件、監管變動或其他外部因素。
用戶在作出任何投資決策前，應自行研究並諮詢合資格的財務專業人士。本平台之創建者及營運者概不承擔因依賴相關資訊而導致的任何財務損失或其他損害責任。
投資加密貨幣風險極高，可能損失全部本金。
方法論概覽
我們的 Avidity Biosciences, Inc. 價格預測採用多因素模型，結合：
- 技術分析（移動平均線、震盪指標、圖表形態）
- 機器學習模型（LSTM 網絡、迴歸模型）
- 鏈上指標（交易量、活躍地址、交易所流向）
- 情緒分析（社交媒體、新聞、群眾心理）
- 宏觀因素（通脹、利率、與傳統市場的相關性）
方法論最後審閱日期：
準備好開始交易 Avidity Biosciences, Inc. 了嗎？
加入數千名交易者，今天就開始您的 Avidity Biosciences, Inc. 交易之旅。獲得先進的交易工具和具競爭力的費用。
